| 000 | 01762 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515000914.0 | ||
| 264 | 0 | _c20060118 | |
| 008 | 200601s 0 0 eng d | ||
| 022 | _a0920-3206 | ||
| 024 | 7 |
_a10.1007/s10557-005-2160-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAtalar, Enver | |
| 245 | 0 | 0 |
_aImmediate effects of fluvastain on circulating soluble endothelial protein C and free tissue factor pathway inhibitor in acute coronary syndromes. _h[electronic resource] |
| 260 |
_bCardiovascular drugs and therapy _cMay 2005 |
||
| 300 |
_a177-81 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntigens _xblood |
| 650 | 0 | 4 | _aAntigens, CD |
| 650 | 0 | 4 | _aBlood Coagulation Factors |
| 650 | 0 | 4 |
_aCoronary Disease _xblood |
| 650 | 0 | 4 | _aEndothelial Protein C Receptor |
| 650 | 0 | 4 |
_aFatty Acids, Monounsaturated _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFluvastatin |
| 650 | 0 | 4 |
_aGlycoproteins _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aIndoles _xpharmacology |
| 650 | 0 | 4 |
_aLipoproteins _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aReceptors, Cell Surface _xblood |
| 700 | 1 | _aCoskun, Secuk | |
| 700 | 1 | _aHaznedaroglu, Ibrahim C | |
| 700 | 1 | _aYücel, Neslihan | |
| 700 | 1 | _aOzer, Necla | |
| 700 | 1 | _aSivri, Bulent | |
| 700 | 1 | _aAksoyek, Serdar | |
| 700 | 1 | _aOvunc, Kenan | |
| 700 | 1 | _aOzmen, Ferhan | |
| 773 | 0 |
_tCardiovascular drugs and therapy _gvol. 19 _gno. 3 _gp. 177-81 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10557-005-2160-x _zAvailable from publisher's website |
| 999 |
_c15778061 _d15778061 |
||